Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Authors :: Kevin R, Kelly
Claudia M, Espitia
Pietro, Taverna
Gavin, Choy
Swaminathan, Padmanabhan
Steffan T, Nawrocki
Francis J, Giles
Jennifer S, Carew
Source :: British journal of haematology. 156(1)
Publication Year :: 2011

Subjects :: Pyridazines
Leukemia, Myeloid, Acute
Proto-Oncogene Proteins c-pim-1
Cell Line, Tumor
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Imidazoles
Humans
Drug Synergism
Protein Kinase Inhibitors

Tools